Publication: Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
Issued Date
2015-08-10
Resource Type
Language
eng
Bibliographic Citation
Drug Design, Development and Therapy. Vol.9, 2015, 4515-4549
Suggested Citation
Watshara Shoombuatong, Veda Prachayasittikul, Nuttapat Anuwongcharoen, Napat Songtawee, Teerawat Monnor, Supaluk Prachayasittikul, Virapong Prachayasittikul, Chanin Nantasenamat Navigating the chemical space of dipeptidyl peptidase-4 inhibitors. Drug Design, Development and Therapy. Vol.9, 2015, 4515-4549. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/2123
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
Abstract
This study represents the first large-scale study on the chemical space of inhibitors of dipeptidyl peptidase-4 (DPP4), which is a potential therapeutic protein target for the treatment of diabetes mellitus. Herein, a large set of 2,937 compounds evaluated for their ability to inhibit DPP4 was compiled from the literature. Molecular descriptors were generated from the geometrically optimized low-energy conformers of these compounds at the semiempirical AM1 level. The origins of DPP4 inhibitory activity were elucidated from computed molecular descriptors that accounted for the unique physicochemical properties inherently present in the active and inactive sets of compounds as defined by their respective half maximal inhibitory concentration values of less than 1 µM and greater than 10 µM, respectively. Decision tree analysis revealed the importance of molecular weight, total energy of a molecule, topological polar surface area, lowest unoccupied molecular orbital, and number of hydrogen-bond donors, which correspond to molecular size, energy, surface polarity, electron acceptors, and hydrogen bond donors, respectively. The prediction model was subjected to rigorous independent testing via three external sets. Scaffold and chemical fragment analysis was also performed on these active and inactive sets of compounds to shed light on the distinguishing features of the functional moieties. Docking of representative active DPP4 inhibitors was also performed to unravel key interacting residues. The results of this study are anticipated to be useful in guiding the rational design of novel and robust DPP4 inhibitors for the treatment of diabetes.